Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Adenocarcinoma, Basal Cell

isoxazoles has been researched along with Adenocarcinoma, Basal Cell in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19904 (25.00)18.7374
1990's1 (6.25)18.2507
2000's1 (6.25)29.6817
2010's8 (50.00)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Czerski, A; Czyżnikowska, Ż; Jęśkowiak, I; Mączyński, M; Regiec, A; Sochacka-Ćwikła, A; Wiatrak, B1
Cheng, B; Li, D; Liu, Y; Song, Y; Wang, Q; Yang, S; Zhang, Y; Zhu, C1
Azzoli, CG; Costa, DB; Gainor, JF; Heist, RS; Huberman, M; Lennes, IT; Muzikansky, A; Oxnard, GR; Piotrowska, Z; Sequist, LV; Shaw, AT1
Basu, G; Bhattacharyya, B; Chakrabarti, P; Chakraborti, G; Chakraborti, S; Das, A; Dhar, G; Dwivedi, V; Poddar, A; Surolia, A1
Fernandes, J; Jampol, LM; Johnson, ML; Mets, M; Munk, MR; Patel, JD1
Biederman, RW; Boyd, NH; DiCarlo, C; Finley, G; Jobe, BA; Kelly, LA; Kolano, EL; Komatsu, Y; Kosovec, JE; Landreneau, RJ; Matsui, D; Omstead, A; Rotoloni, CL; Silverman, JF; Vytlacil, C; Zaidi, AH1
Hedley, D; Krzyzanowska, MK; Moore, MJ; Renouf, DJ; Schmuck, M; Wang, L1
Chihong, Z; Danying, W; Dong, Y; Huaying, S; Jianguo, F; Xiaoqian, Q1
Bucala, R; Crichlow, GV; Leng, L; Lolis, E; Meier, J; Mitchell, RA; Rendon, BE; Riggs, R; Smith, N; Trent, JO; Winner, M; Zierow, S1
Cebrián, C; Conde, B; Esquivias, P; Esteva, F; Jiménez, P; Lanas, A; Ortego, J; Piazuelo, E; Santander, S1
Gibbs, TC; Knoepp, SM; Meier, KE; Park, JJ; Rubio, MV; Snider, AJ; Um, T; Xie, Y; Zhang, Z1
Arakawa, M; Ardalan, B; Cooney, DA; Jayaram, H; Villacorte, D1
Cripps, C; Eisenhauer, E; Fields, AL; Maroun, JA; Pater, JL; Stewart, DJ1
Bakker, CT; Jansen, PL; Oude Elferink, RP1
Davis, TE; Earhart, RH; Faraggi, D; Khandekar, JD; Schinella, RA1
Booth, BW; Budman, D; Ellison, RR; Khojasteh, A; Korzun, AH; Weiss, RB; Wood, W1

Trials

4 trial(s) available for isoxazoles and Adenocarcinoma, Basal Cell

ArticleYear
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 10-01, Volume: 29, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cohort Studies; ErbB Receptors; Exons; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Male; Middle Aged; Mutagenesis, Insertional; Prognosis; Resorcinols; Survival Rate

2018
A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer.
    Cancer chemotherapy and pharmacology, 2016, Volume: 78, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; Middle Aged; Neoplasm Metastasis; Resorcinols; Survival Rate; Treatment Outcome

2016
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Investigational new drugs, 1989, Volume: 7, Issue:2-3

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Infusions, Intravenous; Isoxazoles; Middle Aged; Ovarian Neoplasms; Oxazoles

1989
Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:10

    Topics: Adenocarcinoma; Aged; Antibiotics, Antineoplastic; Brain Diseases; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Neoplasm Metastasis; Oxazoles

1986

Other Studies

12 other study(ies) available for isoxazoles and Adenocarcinoma, Basal Cell

ArticleYear
New Oxazolo[5,4-
    International journal of molecular sciences, 2022, Oct-02, Volume: 23, Issue:19

    Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Cisplatin; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Isoxazoles; Molecular Docking Simulation; Molecular Structure; Purines; Pyrimidines; Structure-Activity Relationship; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2022
MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
    Scientific reports, 2020, 04-21, Volume: 10, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biological Assay; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diffusion Chambers, Culture; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms; RNA, Messenger; Signal Transduction; Transcription Factor RelA; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays

2020
Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin.
    Biochemistry, 2013, Oct-22, Volume: 52, Issue:42

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Proliferation; Curcumin; Flow Cytometry; Free Radical Scavengers; Humans; Isoxazoles; Ketones; Lung Neoplasms; Models, Chemical; Molecular Conformation; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2013
Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.
    JAMA ophthalmology, 2014, Volume: 132, Issue:7

    Topics: Adenocarcinoma; Aged; Autoantibodies; Autoantigens; Electroretinography; Erlotinib Hydrochloride; HSP90 Heat-Shock Proteins; Humans; Infusions, Intravenous; Isoxazoles; Lung Neoplasms; Male; Night Blindness; Paraneoplastic Syndromes, Ocular; Phosphopyruvate Hydratase; Quinazolines; Resorcinols; Retina; Tomography, Optical Coherence; Visual Acuity

2014
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma.
    Annals of surgery, 2016, Volume: 264, Issue:2

    Topics: Adenocarcinoma; Animals; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Esophageal Neoplasms; HSP90 Heat-Shock Proteins; Isoxazoles; Male; Rats; Rats, Sprague-Dawley; Resorcinols

2016
Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Dec-21, Volume: 22

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clone Cells; Enzyme Inhibitors; GTP-Binding Proteins; Humans; Isoxazoles; Lung Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Radiation-Sensitizing Agents; Radiation, Ionizing; Transglutaminases; Tumor Suppressor Protein p53

2016
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
    Cancer research, 2008, Sep-15, Volume: 68, Issue:18

    Topics: Adenocarcinoma; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Humans; Intramolecular Oxidoreductases; Isoxazoles; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Models, Molecular; Pyrimidines

2008
Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    International journal of oncology, 2012, Volume: 40, Issue:2

    Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Esophageal Neoplasms; Female; Gene Expression; Humans; Indomethacin; Isoxazoles; Male; Mice; Mice, Nude; Random Allocation; Receptors, Prostaglandin E; Tumor Burden; Xenograft Model Antitumor Assays

2012
Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.
    The Prostate, 2012, Volume: 72, Issue:15

    Topics: Adenocarcinoma; Animals; Calpain; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Drug Screening Assays, Antitumor; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Ionomycin; Isoxazoles; Lysophospholipids; Male; Paxillin; Phosphorylation; Propionates; Prostatic Neoplasms; Proteolysis; Rats; Thapsigargin

2012
Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
    Biochemical pharmacology, 1982, Apr-15, Volume: 31, Issue:8

    Topics: Adenocarcinoma; Animals; Azaserine; Colonic Neoplasms; Diazooxonorleucine; Glutamine; Intestine, Small; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Neoplasms, Experimental; Pentosephosphates; Phosphoribosyl Pyrophosphate

1982
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Cancer treatment reports, 1984, Volume: 68, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Central Nervous System Diseases; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Infusions, Parenteral; Isoxazoles; Male; Middle Aged; Oxazoles; Rectal Neoplasms

1984
Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells).
    The Biochemical journal, 1993, Mar-15, Volume: 290 ( Pt 3)

    Topics: Adenocarcinoma; Adenosine Triphosphate; Biological Transport, Active; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dinitrochlorobenzene; Dinitrophenols; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Humans; Isoxazoles; Tumor Cells, Cultured

1993